Regulatory Balance Act - Requires the Secretary of Agriculture, the Administrator of the Environmental Protection Agency (EPA), and the Commissioner of the Food and Drug Administration (FDA) to perform a cost-benefit analysis on any proposed regulation that is determined to be a significant regulatory action (as defined by Executive Order 12866) and submit such analysis to Congress before such regulation takes effect.
[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2175 Introduced in House (IH)]
112th CONGRESS
1st Session
H. R. 2175
To require certain agencies to submit a cost-benefit analysis to the
Congress before implementing proposed regulations.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
June 14, 2011
Mr. Fincher introduced the following bill; which was referred to the
Committee on Energy and Commerce, and in addition to the Committees on
Agriculture and Transportation and Infrastructure, for a period to be
subsequently determined by the Speaker, in each case for consideration
of such provisions as fall within the jurisdiction of the committee
concerned
_______________________________________________________________________
A BILL
To require certain agencies to submit a cost-benefit analysis to the
Congress before implementing proposed regulations.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Regulatory Balance Act''.
SEC. 2. COST-BENEFIT ANALYSIS REQUIRED WITH RESPECT TO SIGNIFICANT
REGULATORY ACTIONS OF THE ENVIRONMENTAL PROTECTION
AGENCY, DEPARTMENT OF AGRICULTURE, AND FOOD AND DRUG
ADMINISTRATION.
Before any proposed regulation that is determined to be a
significant regulatory action, as such term is defined in Executive
Order 12866 (5 U.S.C. 601 note; relating to regulatory planning and
review), takes effect, the Secretary of Agriculture, the Administrator
of the Environmental Protection Agency, and the Commissioner of the
Food and Drug Administration shall--
(1) perform the cost-benefit analysis described in section
6(a)(3) of such Executive Order (or any successor thereto) for
such proposed regulation; and
(2) submit such analysis to the Congress.
<all>
Introduced in House
Introduced in House
Sponsor introductory remarks on measure. (CR E1091)
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Agriculture, and Transportation and Infrastructure, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Water Resources and Environment.
Referred to the Subcommittee on Environment and the Economy.
Referred to the Subcommittee on Department Operations, Oversight, and Credit.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line